Search results for "Adverse Events"
COVID-19 studies offer risk scores, experts issue guidance on vaccine prioritization
One study found that albumin was key to identifying COVID-19 patients safe to discharge, while another suggested CT findings could be helpful in diagnosis and triage. The Advisory Committee on Immunization Practices and ACP considered who should be vaccinated first, and the CDC revised quarantine advice.
https://acphospitalist.acponline.org/weekly/archives/2020/12/09/1.htm
9 Dec 2020
Latest inpatient COVID-19 research looks at plasma, intubation, delirium, VTE, and more
Recent studies showed that convalescent plasma didn't improve outcomes, a protocol reduced intubation rates, delirium was a common presentation among elderly patients, venous thromboembolism (VTE) was more common in the ICU, and racial disparities persisted after adjustment.
https://acphospitalist.acponline.org/weekly/archives/2020/11/25/2.htm
25 Nov 2020
New guidelines, authorizations on remdesivir, bamlanivimab, other drugs for COVID-19
The World Health Organization and Infectious Diseases Society of America (IDSA) changed their guidelines to be less favorable to remdesivir. Both the IDSA and NIH expressed reservations about bamlanivimab, while the FDA issued two new emergency use authorizations.
https://acphospitalist.acponline.org/weekly/archives/2020/11/25/1.htm
25 Nov 2020
Displaying patient photographs in EHR reduced rate of wrong-patient order entry errors
As part of a quality improvement project at one Boston hospital, ED staff encouraged patients to have their photographs taken by informing them that the project was intended to improve safety.
https://acphospitalist.acponline.org/weekly/archives/2020/11/18/5.htm
18 Nov 2020
New warnings on benzodiazepines
Recalls, warnings, and approvals.
https://acphospitalist.acponline.org/archives/2020/11/fda-update-new-warnings-on-benzodiazepines.htm
15 Nov 2020
COVID-19 flu guidance, data on convalescent plasma, cardiac effects, and clot risk
Flu testing and treatment advice came from the NIH, convalescent plasma failed in a trial, new studies suggested looking out for myocardial injury and not overdoing thromboprophylaxis, and remdesivir got full approval, among other COVID-19 news.
https://acphospitalist.acponline.org/weekly/archives/2020/10/28/1.htm
28 Oct 2020
Syncope, sepsis resuscitation, and more
Research summaries from ACP Hospitalist Weekly.
https://acphospitalist.acponline.org/archives/2020/10/recent-research.htm
15 Oct 2020
Infusion sets, heparin recalled
Recalls, warnings, and approvals.
https://acphospitalist.acponline.org/archives/2020/10/fda-update-infusion-sets-heparin-recalled.htm
15 Oct 2020
More data on risk factors for poor COVID-19 outcomes, mixed results from treatment trials
A risk calculator, genetic findings, and red blood cell distribution width helped predict severity of and death from COVID-19. Tocilizumab showed benefit, but a number of other treatments, including CPR, did not, according to recent research.
https://acphospitalist.acponline.org/weekly/archives/2020/09/30/1.htm
30 Sep 2020
EVALI, rapid response, and more
Research summaries from ACP Hospitalist Weekly.
https://acphospitalist.acponline.org/archives/2020/09/in-the-news.htm
15 Sep 2020